Logo image
Dihydropyridine receptor (DHPR, CACNA1S) congenital myopathy
Journal article   Open access   Peer reviewed

Dihydropyridine receptor (DHPR, CACNA1S) congenital myopathy

Vanessa Schartner, Norma B Romero, Sandra Donkervoort, Susan Treves, Pinki Munot, Tyler Mark Pierson, Ivana Dabaj, Edoardo Malfatti, Irina T Zaharieva, Francesco Zorzato, …
Acta neuropathologica, Vol.133(4), pp.517-533
04/2017
DOI: 10.1007/s00401-016-1656-8
PMID: 28012042
url
https://doi.org/10.1007/s00401-016-1656-8View
Published (Version of record) Open Access

Abstract

Muscle contraction upon nerve stimulation relies on excitation-contraction coupling (ECC) to promote the rapid and generalized release of calcium within myofibers. In skeletal muscle, ECC is performed by the direct coupling of a voltage-gated L-type Ca channel (dihydropyridine receptor; DHPR) located on the T-tubule with a Ca release channel (ryanodine receptor; RYR1) on the sarcoplasmic reticulum (SR) component of the triad. Here, we characterize a novel class of congenital myopathy at the morphological, molecular, and functional levels. We describe a cohort of 11 patients from 7 families presenting with perinatal hypotonia, severe axial and generalized weakness. Ophthalmoplegia is present in four patients. The analysis of muscle biopsies demonstrated a characteristic intermyofibrillar network due to SR dilatation, internal nuclei, and areas of myofibrillar disorganization in some samples. Exome sequencing revealed ten recessive or dominant mutations in CACNA1S (Ca 1.1), the pore-forming subunit of DHPR in skeletal muscle. Both recessive and dominant mutations correlated with a consistent phenotype, a decrease in protein level, and with a major impairment of Ca release induced by depolarization in cultured myotubes. While dominant CACNA1S mutations were previously linked to malignant hyperthermia susceptibility or hypokalemic periodic paralysis, our findings strengthen the importance of DHPR for perinatal muscle function in human. These data also highlight CACNA1S and ECC as therapeutic targets for the development of treatments that may be facilitated by the previous knowledge accumulated on DHPR.
Family Mutation Phenotype Adolescent Adult Calcium - metabolism Calcium Channels - genetics Calcium Channels - metabolism Cells, Cultured Child Cohort Studies Female Humans Male Middle Aged Muscle Cells - metabolism Muscle Cells - pathology Muscle, Skeletal - diagnostic imaging Muscle, Skeletal - metabolism Muscle, Skeletal - pathology Myotonia Congenita - diagnostic imaging Myotonia Congenita - genetics Myotonia Congenita - metabolism Myotonia Congenita - pathology Sequence Homology, Amino Acid Young Adult

Details

Metrics

Logo image